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P-glycoprotein (P-gp) is an ABC (ATP-Binding Cassette) drug pump. A common feature of ABC proteins is
that they are organized into two wings. Each wing contains a transmembrane domain (TMD) and a
nucleotide-binding domain (NBD). Drug substrates and ATP bind at the interface between the TMDs and
NBDs, respectively. Drug transport involves ATP-dependent conformational changes between inward-
(open, NBDs far apart) and outward-facing (closed, NBDs close together) conformations. P-gps crystal-
lized in the presence of detergent show an open structure. Human P-gp is inactive in detergent but basal
ATPase activity is restored upon addition of lipids. The lipids might cause closure of the wings to bring
the NBDs close together to allow ATP hydrolysis. We show however, that cross-linking the wings
together did not activate ATPase activity when lipids were absent suggesting that lipids may induce other
structural changes required for ATPase activity. We then tested the effect of lipids on disulﬁde cross-
linking of mutants at the ﬁrst transmission interface between intracellular loop 4 (TMD2) and NBD1.
Mutants L443C/S909C and L443C/R905C but not G471C/S909C and V472C/S909C were cross-linked with
oxidant when in membranes. The mutants were then puriﬁed and cross-linked with or without lipids.
Mutants G471C/S909C and V472C/S909C cross-linked only in the absence of lipids whereas mutants
L443C/S909C and L443C/R905C were cross-linked only in the presence of lipids. The results suggest that
lipids activate a switch at the ﬁrst transmission interface and that the structure of P-gp is different in
detergents and lipids.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
P-glycoprotein (P-gp) is an ABC (ATP-binding cassette) protein
that can pump awide variety of cytotoxic compound out of the cell.
Overexpression of P-gp can lead to the phenomenon of multidrug
resistance during chemotherapy [1]. P-gp contains two homolo-
gous halves with each half containing six transmembrane (TM)
segments and a nucleotide-binding domain (NBD) [1]. The two
halves are inactive when expressed as separate proteins but will
form an active transporter when the two halves are co-expressed in
the same cell [2]. The two halves form two wings. One wing con-
sists of NBD1 and transmembrane (TM) segments 1, 2, 3, 6, 10 and
11 while the other consists of NBD2 and TMs 4 5, 7, 8, 9 and 12. The-glycoprotein; NBD, nucleo-
; TM, transmembrane; TMD,
niversity of Toronto, 1 King's
Toronto, Ontario, M5S 1A8,
arke).
r Inc. This is an open access articleintracellular (ICL) loops between TMs 2/3 (ICL1) and 10/11(ICL4)
interact with NBD1 to form the ﬁrst transmission interface while
the loops between TMs 4/5 (ICL2) and 8/9 (ICL3) interact with NBD2
to form the second transmission interface [3]. Drug substrates bind
at the interface between the TMDs [4]. P-gp acts as a membrane
‘vacuum cleaner’ [5] that extracts drug substrates out of the inner
leaﬂet of the lipid bilayer [6]. Drug substrates activate ATPase ac-
tivity [7]. The catalytic cycle of P-gp transport is predicted to be
similar to other ABC exporters [8]. The mechanism involves
conformational changes occurring when drug substrate is bound to
P-gp in the open state and when it is released to the cell exterior
during the closed state (Fig. 1A).
Crystal structures for mouse [9] and Caenorhabditis elegans P-
gps [10] in open inward-facing conformations are consistent with
the results of many biochemical studies [11e15]. The crystal
structures however, were determined in the presence of detergent.
A recent study on MsbA suggested that ABC crystal structures ob-
tained in detergent may not be physiological because of the large
separation of the NBDs [16].
We have observed that puriﬁed human P-gp exhibits negligible
basal ATPase activity in the absence of lipids. It is possible that theunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Activation of P-gp ATPase activity after clamping the wings together requires
lipid. (A) Predicted structures of human P-gp in the open [10] and the closed confor-
mations [38]. The models were viewed using the PyMol system [39]. TMs 1e6 are
shown in blue and TMs 7e12 are shown in yellow. The branched lines between TM
segments 1 and 2 represent glycosylated sites. The L175C(ICL1)/N820C(ICL3) cross-
linkable cysteines are located in the cytoplasmic loops that connects the TMDs to
the NBDs. (B) Membranes prepared from HEK 293 cells expressing mutant L175C/
N820C were treated in the absence (Not X-linked) or presence (X-linked) of M4M
cross-linker and the P-gps were isolated by nickel-chelate chromatography. Samples
were subjected to immunoblot analysis after treatment with (þ) or without () 10 mM
dithiothreitol (DTT). The locations of mature (170 kDa) and cross-linked (X-link) P-gps
are indicated (inset). The ATPase activities of the cross-linked and uncross-linked P-gps
were determined in the presence (þLipid) or absence (- Lipid) of lipids after treatment
with (þ) or without () 10 mM dithiothreitol (DTT). Each value is the mean ± S.D.
(n ¼ 3). The asterisk indicates signiﬁcant difference (P < 0.001) relative to the sample
treated with DTT as well as to those measured without lipid.
T.W. Loo, D.M. Clarke / Biochemical and Biophysical Research Communications 472 (2016) 379e383380Walker A and the opposing LSGGQ sites in the NBDs are too far
apart (>30 Å) in detergent for ATP hydrolysis [10]. To test if high
levels of ATPase activity could be obtained in the absence of lipids,
we cross-linked P-gp in a closed conformation. We found that
clamping P-gp in a closed conformation activated ATPase activity
only in the presence of lipids. The results suggested that lipids
affected other domainedomain interface(s) such as the trans-
mission interfaces connecting the NBDs to the TMDs that are
required for ATPase activity. The ﬁrst transmission interface was
previously shown to be less sensitive to mutations than the second
transmission interface [17,18] suggesting that the ﬁrst transmission
interfacemight be quitemalleable. Herewe show that cross-linking
of residues at the ﬁrst transmission interface in puriﬁed P-gp is
affected by the presence of lipids.
2. Materials and methods
2.1. Construction of mutants
Mutations were introduced into Cys-less P-gp cDNA containinga 10-histidine tag [19] to introduce pairs of cysteines by site-
directed mutagenesis as described by Kunkel [20]. Mutant L175C/
N820C was used to test the effects of cross-linking the two wings
together [21]. The L175C cysteine is located in the N-terminal wing
(Fig. 1A) and N820C is located in the other wing. The G471C/S909C,
V472C/S909C, L443C/S909C, L443C/R905C mutants were con-
structed to monitor cross-linking at the ﬁrst transmission interface
between NBD1 and intracellular loop 4 (ICL4) in TMD2.
2.2. Disulﬁde cross-linking analysis
Cys-less P-gp mutants containing pairs of cysteines were
expressed in HEK 293 cells in the presence of 5 mM cyclosporine A
at 37 C in the presence of 5 mM sodium butyrate for 24 h and then
incubated at 30 C for 24 h. Sodium butyrate is a histone deacety-
lase inhibitor that enhances expression of proteins in HEK 293 cells
[22]. Cyclosporine A and low temperature incubation promote
maturation of the mutants [23].
To test the effects of clamping the wings together, membranes
were prepared from ﬁfty 10 cm plates of cells expressing histidine-
tagged L175C/N820C P-gp as described previously [21]. The mem-
branes were suspended in 1.5 ml of Tris-buffered saline (TBS), pH
7.4. Equivalent amounts of membranes were treated with or
without 0.02 mM 1,4-butanediyl bismethanethiosulfonate (M4M,
spans 4.9e6.5 Å) cross-linker at 20 C for 5 min. A sample of the
reaction mixtures was added to 2 X SDS sample buffer (125 mM
TriseHCl, pH 6.8, 20% (v/v) glycerol and 4% (w/v) SDS) containing
25 mM EDTA and no reducing agent. The reaction mixtures were
then subjected to SDS-PAGE (6.5% (w/v) polyacrylamide gels) and
immunoblot analysis with a rabbit polyclonal antibody against P-gp
[24]. Intramolecular disulﬁde cross-linking between domains can
be detected because the cross-linked product migrates with a
slower mobility on SDS-PAGE gels [25].
2.3. Measurement of ATPase activity
Histidine-tagged P-gp mutant L175C/N820C was treated with or
without M4M and isolated by nickel-chelate chromatography as
described previously [26]. Recovery of P-gp was monitored by
immunoblot analysis with rabbit anti-P-gp polyclonal antibody
[24]. A sample of the isolated histidine-tagged P-gp in 0.1% (w/v) n-
dodecyl-b-D-maltoside was mixed with an equal volume of 10 mg/
ml total Escherichia coli (E. coli) lipids (Avanti Polar Lipids, Inc.)
(lipid-rich detergent micelles) or TBS, pH 7.4. The P-gp:lipid
mixture was then sonicated for 45 s at 4 C (bath type probe,
maximum setting, Branson Soniﬁer 450, Branson Ultrasonic, Dan-
bury, CT) and ATPase activity determined in the presence or
absence of 10 mM dithiothreitol (DTT) as described previously [17].
E. coli lipids were used because basal ATPase activity is signiﬁcantly
higher in these lipids than in sheep brain phosphatidylethanol-
amine used in previous studies [27] and is often used to test if a
compound is an inhibitor of (basal) P-gp ATPase activity [27]. E. coli
lipids are functionally relevant because drug-stimulated ATPase
activity of P-gp reconstituted with this lipid is similar to that
measured in isolated mammalian plasma membranes (from drug-
resistant cell lines) that are enriched in P-gp [28].
To test for NBD1/ICL4 interactions, histidine-tagged Cys-less P-
gp, mutants G471C/S909C, V472C/S909C, L443C/S909C or L443C/
R905C were transiently expressed in HEK 293 cells. Membranes
were prepared and samples were treated with or without oxidant
(1 mM copper phenanthroline) for 5 min at 20 C. The reactions
were stopped by addition of EDTA (10 mM ﬁnal concentration). The
samples were then mixed with 1 volume of 2X SDS sample buffer
containing 25 mM EDTA with no reducing agent and samples
subjected to immunoblot analysis as described above.
Fig. 2. Cross-linking of double cysteine mutants at the ﬁrst transmission interface. (A)
The location of the ﬁrst transmission interface (boxed) between ICL4/NBD1 is shown in
a model of human P-gp in the open conformation [9] and (B) the residues
Leu443(NBD1), Gly471(NBD1), Val472(NBD1), Arg905(ICL4) and Ser909(ICL4) to be
mutated to cysteine at the interface. (C) ATPase activities of the histidine-tagged un-
cross-linked double cysteine mutants isolated by nickel-chelate chromatography in the
presence (þ) or absence () of lipids. Each value is the mean ± S.D. (n ¼ 3e5) An
asterisk indicated signiﬁcant difference (P < 0.001) relative to a sample assayed
without lipid. (D) Membranes prepared from cells expressing the mutants were
treated with (þ) or without () copper phenanthroline (CP). Samples were subjected
to immunoblot analysis (inset). The position of cross-linked (X-link) and mature
(170 kDa) P-gp is shown. The amount of cross-linked P-gp relative to total was
determined. Each value is the mean ± S.D. (n ¼ 3e5). An asterisk indicates signiﬁcant
difference (P < 0.001) relative to a sample not treated with CP.
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chromatography and samples assayed for ATPase activity in the
presence or absence of 2 mg/ml lipids. Samples of isolated P-gps
were mixed with 2 mg/ml lipids or TBS, pH 7.4 and treated with or
without oxidant (1 mM copper phenanthroline) for 5 min at 20 C.
The reactions were stopped by addition of EDTA (10 mM ﬁnal
concentration) followed by an equal volume of 2X SDS sample
buffer containing 25 mM EDTA but no reducing agent. The samples
were then subjected to SDS-PAGE and immunoblot analysis as
described above.
2.4. Data analysis
ChemiDoc™ XRSþwith Image Lab™ software (Bio-Rad Lab. Inc.,
Mississauga, Ontario) was used to record and quantify the signals
from the immunoblots. The results were expressed as an average of
triplicate experiments ± standard deviation (S.D.). The Student's
two-tailed t-test was used to determine statistical signiﬁcance
(P < 0.001).
3. Results and discussion
We previously found that isolated human P-gp shows negligible
ATPase activity in the absence of lipids (also see Fig. 1B). One
explanation is that P-gp adopts a wide-open conformation in
detergent without lipids as reported in the crystal structures
[9,10,29] such that the NBDs are too far apart (greater than 30 Å
apart) to form a dimer that is necessary for ATP binding and hy-
drolysis. Lipids may promote formation of a more closed confor-
mation as observed for MsbA [16]. Does P-gp show high ATPase
activity in the absence of lipids if it was locked in a closed confor-
mation? To address this question we used mutant L175C/N820C
that has a cysteine in each wing of P-gp (Fig. 1A). Cross-linking
mutant L175C/N820C with a short cross-linker (M4M; 4.9e6.5 Å)
traps P-gp in a closed conformation that exhibits high ATPase ac-
tivity in the presence of lipids [30]. If lipids simply enhance for-
mation of a closed conformation, then cross-linked L175C/N820C
would be expected show high ATPase activity in the absence of
lipids.
Membranes prepared from HEK 293 cells expressing histidine-
tagged L175C/N820C P-gp were treated with or without M4M
cross-linker. Both cross- and uncross-linked P-gps were then iso-
lated by nickel-chelate chromatography. Cross-linking causes P-gp
to migrate slower on SDS-PAGE gels (see Fig. 1B) and was abolished
when treated with DTT (Fig. 1B). The isolated P-gps were then
mixed with E. coli lipids or TBS, pH 7.4 and ATPase activity
measured. As shown in Fig. 1B, uncross-linked mutant had no
detectable ATPase activity in the absence of lipids. The activity
increased to about 0.5 mmol/min/mg P-gp in the presence of lipids
regardless of whether the sample was treated with DTT. In contrast,
cross-linking increased the activity of L175C/N820C to 1.7 mmol/
min/mg P-gp in the presence of lipids (Fig. 1B). The increase in
activity was due to cross-linking as treatment with DTT reduced the
activity to that of uncross-linked P-gp (about 0.5 mmol/min/mg P-
gp). Without lipids however, cross-linked L175C/N820C showed
little ATPase activity in the presence or absence of DTT. Therefore
lipids do not simply promote formation of a more closed confor-
mation but also induce other structural changes to switch P-gp into
a high ATPase activity mode.
Stimulation of P-gp ATPase activity may be a two-step process.
The ﬁrst step might be to promote interaction between the two
wings to bring the NBDs together to allow ATP molecules to bind at
the NBD1/NBD2 interface followed by switching of the trans-
mission interfaces into active modes. The transmission interfaces of
ABC transporters [31] consist of loops that connect cytoplasmicextensions of TM segments in the TMDs to the NBDs. It is thought
that conformational changes in the NBDs as a result of ATP binding/
hydrolysis are transmitted to the TMDs through these interfaces
(NBD1/ICL1/ICL4 at the ﬁrst transmission interface and NBD2/ICL2/
ICL3 at the second transmission interface). The NBD1/ICL4 and
NBD2/ICL2 contact points appear to be more important for activity
in ABC drug pumps than the NBD1/ICL1 and NBD2/ICL3 contact
points because some drug pumps (e.g. BCRP; ABCG2) do not have
the latter [32].
We then tested whether lipids affected the disulﬁde cross-
linking patterns at the ﬁrst transmission interface (NBD1/ICL4)
(Fig. 2A). The NBD1/ICL4 transmission interface was selected rather
than the NBD2/ICL2 interface because it is much less sensitive to
mutations [17]. The NBD2/ICL2 interface is highly sensitive to point
mutations with the majority of mutations severely inhibiting
folding and/or activity of P-gp [17]. By contrast, mutations in the
ﬁrst transmission interface do not seem to affect assembly and
activity of the protein.
Fig. 3. Lipid activates a switch at the NBD1/ICL4 interface. (A) Histidine-tagged mu-
tants (G471C/S909C, V472C/S909C, L443C/S909C and L443C/R905C were isolated by
nickel chelate chromatography, mixed with (þLipid) or without (- Lipid) lipids and
treated with (þ) or without () copper phenanthroline (CP). Samples were subjected
to immunoblot analysis. The position of cross-linked (X-link) and mature (170 kDa) P-
gp is shown. The level of cross-linked P-gp relative to total was determined (B). Each
value is the mean ± S.D. (n ¼ 3e5). An asterisk indicates signiﬁcant difference
(P < 0.001) relative to samples not treated with CP. Models of the NBD1/ICL4 interface
in the absence (C) and presence (D) of lipid are shown. In the absence of lipids, P-gp
adopts the ‘off’ conformation with negligible basal ATPase activity and with Ser909
close to Gly471 or Val472 while the presence of lipids causes P-gp to adopt the ‘on’
conformation that exhibits high ATPase activity and with S909C close to L443C. For
clarity, the L443/R905 interaction is not shown.
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cysteine mutants (G471C (NBD1)/S909C (ICL4), V472C(NBD1)/
S909C(ICL4), L443C(NBD1)/S909C(ICL4), L443C(NBD1)/
R905C(ICL4)) at the NBD1/ICL4 interface [10] (Fig. 2B). The R905C
and S909C mutations are located in intracellular helix loop 4 (IH4)
that links the cytoplasmic extensions of TM segments 10 and 11.
The cysteine replacements at positions G471C and V472C in NBD1
lie close to the Q-loop (residue Gln475 is predicted to co-ordinate
with the g-phosphate of ATP) [33] while L443C lies close to the
Walker A sequence for binding of ATP. The mutants were expressed
in HEK 293 cells, isolated by nickel-chelate chromatography, mixed
with lipids and assayed for ATPase activity. All mutants had negli-
gible basal ATPase activity in the absence of lipids (Fig. 2C). In the
presence of lipids, however, the mutants exhibited basal ATPase
activities that were similar to the Cys-less parent (Fig. 2C).
When membranes prepared from cells expressing the mutants
were treated with oxidant, it was observed that only mutants
L443C/R905C and L443C/S909C showed robust cross-linking
(Fig. 2D). The results were surprising since the crystal structures
and models of human P-gp [9,10,29] showed that the distance be-
tween the a-carbons in G471C/S909C and V472C/S909C are closer
to each other (7.4e8.6 Å) than in mutants L443C/R905C or L443C/
S909C (8.3e11.6 Å) (Table 1).
It was possible that the mutants with cysteines predicted to be
farther apart were cross-linked (Fig. 2D) because the presence of
lipids alters interaction at this transmission interface. To address
this possibility the histidine-tagged mutants G471C/S909C, V472C/
S909C, L443C/S909C or L443C/R905C were expressed in HEK
293 cells and isolated by nickel chromatography to remove the
lipids. The puriﬁed mutants were then cross-linked with oxidant in
the presence or absence of lipids. In the absence of lipids, mutants
G471C/S909C and V472C/S909C showed robust cross-linking
(Fig. 3A and B). By contrast, mutants L443C/S909C and L443C/
R905C were cross-linked only in the presence of lipids (Fig. 3A and
B). All four double-cysteine mutants retained over 95% of their
activity when they were left without lipids for 45 min at 20 C and
then assayed for ATPase activity in the presence of lipid (data not
shown). This suggests that the cross-linking results were not due to
the stabilizing effect of lipids.
The results of this study suggest that lipids cause conforma-
tional changes at the ﬁrst transmission interface to activate ATPase
activity (Fig. 2C and D). Without lipids, P-gp shows little ATPase
activity as residue Ser909 in IH4 lies close to Gly471 and Val472 in
NBD1. The presence of lipids activates a switch to promote ATPase
activity bymoving Ser909 closer to Leu443 and away fromGly471 and
Val472. Conformational changes at the ﬁrst transmission interface
are critical for activity as cross-linking of mutant L443C/S909C
inhibited drug-stimulated ATPase activity by more than 90% [34].
Our results are consistent with studies on MsbA [35] showing
that lipids are required to activate the ATPase activity of ABC export
proteins. It was found that lipids did not alter the structure of the
NBDs but suggested that they altered functional interactions be-
tween domains. A LRET spectroscopy study of MsbA showed that
lipids caused a signiﬁcantly smaller separation between the NBDsTable 1
Distances between the a-carbons of residues in various structures and models of P-gp.






G471/S909 8.2 Å 7.9 Å 7.7 Å (A495/A95
V472/S909 7.4 Å 7.5 Å 7.5 Å (V496/A95
L443/S909 8.4 Å 8.9 Å 8.8 Å (Y467/A95
L443/R905 9.4 Å 8.3 Å 8.1 Å (Y467/R946
a These residues are at equivalent positions to those in human P-gp.than was observed in the crystal structure of MsbA in an open
inward-facing conformation [36]. Small separations between the
NBDswere also observed in ﬂuorescence resonance energy transfer
(FRET) studies of mouse P-gp incorporated into lipids [37]. The LRET
and FRET studies suggest that incorporation of ABC transporters
into lipids narrows the average distances between the NBDs.
The cross-linking studies suggest that lipids can induce further







0)a 8.2 Å (G467/S905)a 7.9 Å (G467/S905)a 8.6 Å
0)a 7.4 Å (V468/S905)a 8.4 Å (V468/S905)a 7.3 Å
0)a 8.8 Å (L439/S905)a 11.6 Å (L439/S905)a 8.3 Å
)a 9.4 Å (L439/R901)a 11.1 Å (L439/R901)a 9.0 Å
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required to activate a switch at the ﬁrst transmission interface. Our
study shows that lipids can also modulate NBD/TMD interactions
and that the structure of P-gp may show signiﬁcant differences in
detergent and lipids.
In summary, our results show that the structure at the ﬁrst
transmission interface (NBD1/ICL4) that is important for NBD/TMD
cross talk is affected by the presence of lipids. Lipids activate an
intriguing and novel conformational switch for coupling substrate
transport to ATP hydrolysis in ABC proteins.
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